Imperial College London has secured £22.5m from the UK Government to accelerate the development of a potential Covid-19 vaccine.
Since February, researchers at Imperial have been studying a self-amplifying RNA vaccine candidate in animals.
Go deeper with GlobalData
The government funding will be used to support Phase II trials and to make preparations for a large Phase III trial.
